Effects of Chlorella on activities of protein tyrosine phosphatases, matrix metalloproteinases, caspases, cytokine release, B and T cell proliferations, and phorbol ester receptor binding

Journal of Medicinal Food

Volumn 7, Issue 2, 2004, Pages 146-152

  Cheng, Fong Chi ^a   Lin, Atsui ^a   Feng, Jin Jye ^a   Mizoguchi, Toru ^b   Takekoshi, Hideo ^b   Kubota, Hitoshi ^b   Kato, Yoko ^b   Naoki, Yo ^b  

^a MDS Pharma Services   (Taiwan)

^b Sun Chlorella Corp   (Japan)

Author keywords

Caspases; Chlorella; Cytokines; Matrix metalloproteinases; Phorbol ester; Protein tyrosine phosphatase

Indexed keywords

CASPASE; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CELL RECEPTOR; CHLORELLA PYRENOIDOSA EXTRACT; CYTOKINE; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; NATURAL PRODUCT; PHORBOL DIACETATE; PHORBOL ESTER; PROTEIN TYROSINE PHOSPHATASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CHLORELLA; CHLORELLA PYRENOIDOSA; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ACTIVITY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POWDER; PRIORITY JOURNAL; RECEPTOR BINDING; SPLEEN CELL; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ANTIGENS, CD45; B-LYMPHOCYTES; CASPASES; CHLORELLA; CONCANAVALIN A; CYTOKINES; ENZYME INHIBITORS; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; PROTEIN KINASE C; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, DRUG; T-LYMPHOCYTES;

ANIMALIA; CHLORELLA PYRENOIDOSA;

EID: 3042796449     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/1096620041224076     Document Type: Article

References (46)

1. Hsiuan-Lin W, Ruey-Shyang H, Liang-Ping L: Identification of Chlorella spp. isolates using ribosomal DNA sequences. Bot Bull Acad Sin 2001;42:115-121.
2. Inoue K, Mukaiyama Y, Oka H, Misawa H: Clinical effects of Chlorella in hypertensive men. J Jpn Soc Nutr Food Sci 1995;48:485-489.
3. Murakami T, Iiduka Y, Okamoto K, Oogaki M: Effect of Chlorella on blood pressure, cerebral stroke lesions, hypertensive vascular changes and life-span in spontaneously hypertensive rats. J Jpn Soc Nutr Food Sci 1987;40:351-359.
4. Shibata S, Orita K, Iwabuchi A, Misawa H: Serum cholesterol lowering action of hardly digestible fraction of Chlorella. J Jpn Soc Nutr Food Sci 1998;52:100.
5. Tanaka K, Konishi F, Himeno K, Taniguchi K, Nomoto K: Augmentation of antitumor resistance by a strain of unicellular green algae, Chlorella vulgaris. Cancer Immunol Immunother 1984;17:90-94.
6. Konishi F, Tanaka K, Himeno K, Taniguchi K, Nomoto K: Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes. Cancer Immunol Immunother 1985;19:73-78.
7. Miyazawa Y, Murayama T, Ooya N, Wang LF, Tung YC, Yamaguchi N: Immunomodulation by a unicellular green algae (Chlorella pyrenoidosa) in tumor-bearing mice. J Ethnopharmacol 1988;24:135-146.
8. Tanaka K, Koga T, Konishi F, Nakamura M, Mitsuyama M, Himeno K, Nomoto K: Augmentation of host defense by a unicellular green alga, Chlorella vulgaris, to Escherichia coli infection. Infect Immun 1988;53:267-271.
9. Morita K, Matsueda T, Iida T: Effects of Chlorella, spirulina and chlorophyllin on fecal excretion of polychloronated dibenzo-p-dioxins in rats. Jpn J Toxicol Environ Health 1997;43:42-47.
10. Komiyama K, Hirokawa Y, Morota T, Umezawa I: Antitumor activity and immunological response. Chemotherapy 1986;32:302-307.
11. Kanouchi H, Okabe M, Doi S, Yamada H, Tachibana H, Yamada K: Dietary effect of Chlorella pyrenoidosa powder on immunoglobulin productivity of Sprague-Dawley rats. Nippon Shokuhin Kagaku Kaishi 2001;48:634-636.
12. Johnson P, Ostergaard HL, Wasden C, Trowbridge IS: Mutational analysis of CD45: a leukocyte specific protein tyrosine phosphatase. J Biol Chem 1992;267:8035-8041.
13. Zhang ZY, Thieme-Sefler AM, Maclean D, McNamara DJ, Dobrusin EM, Sawyer TK, Dixon JE: Substrate specificity of the protein tyrosine phosphatases. Proc Natl Acad Sci U S A 1993;90:4446-4450.
14. Pei D, Lorenz U, Klingmuller U, Neel BG, Walsh CT: Intramolecular regulation of protein tyrosine phosphatase SH-PTP1: a new function of src homology domains. Biochemistry 1994;33:15483-15493.
15. D'Ambrosio D, Hippen KL, Minskoff SA, Mellman I, Pani G, Siminovitch KA, Cambier JC: Recruitment and activation of PTP1C in negative regulation of antigen receptor signalling by FrcγRIIB1. Science 1995;268:293-296.
16. Wiener JR, Kerns B-JM, Harvey EL, Conaway MR, Iglehart JD, Berchuck A, Bast RC Jr: Overexpression of the protein phosphatase PTP1B in human breast cancer: association with p185-cerb-2 protein expression. J Natl Cancer Inst 1994;86:372-378.
17. Turner BC, Tonks NH: Interleukin 2 regulates Raf-1 kinase activity through a tyrosine phosphorylation-dependent mechanism in a T-cell line. Proc Natl Acad Sci U S A 1993;90:5544-5548.
18. Knight CG, Willenbrock F, Murphy G: A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 1992;296:263-266.
19. Johnson LL, Dyer R, Hupe DJ: Matrix metalloproteinases. Curr Opin Chem Biol 1998;2:466-471.
20. Olson MW, Gervasi DC, Mobashery S, Fridman R: Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem 1997;272:29975-29983.
21. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin TT, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992;356:768-775.
22. Mittl PR, Di Marco S, Krebs JF, Karanewsky DS, Priestle JP, Tomaselli KJ, Grutter MG: Structure of recombinant human CPP32 in complex with the tetrapeptide Acetyl-Asp-Va1-Ala-Asp fluoromethyl ketone. J Biol Chem 1997;272:6539-6547.
23. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD, Wong WW: Substrate specificities of caspase family proteases. J Biol Chem 1997;272:9677-9682.
24. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in FAS/APO-1- and TNF receptor-induced cell death. Cell 1996;85:803-815.
25. Welker P, Lippert W, Kruger-Krasagakes S, Möller A, Czarnetzki B: Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomocytic cells. Int Arch Allergy Immunol 1996;109:110-115.
26. Dayton JS, Turka LA, Thompson CB, Mitchell BS: Comparison of the effects of myoribine with those of azothiaprine, 6 mercaptopurine and myophenolic acid on T-lymphocyte proliferation and purine ribonucleotide metabolism. Mol Pharmacol 1992;41:671-676.
27. Mishell BB, Shiigi SM, eds.: Cell proliferation. In: Selected Methods in Cellular Immunology, W.H. Freeman Co., San Francisco, 1980, pp. 153-161.
28. Ashendel CL: The phorbol ester receptor: a phospholipid regulated protein kinase. Biochim Biophys Acta 1985;822:219-242.
29. Fischer EH, Charbonneau H, Tonks NK: Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 1991;253:401-406.
30. Schieven GL, Wahl AF, Myrdal S, Grosmaire L, Ledbetter JA: Lineage-specific induction of B cell apoptosis and altered signal transduction by the phosphotyrosine phosphatase inhibitor bis(maltolato)oxovanadium(IV). J Biol Chem 1995;270:20824-20831.
31. Katagiri T, Ogimoto M, Hasegawa K, Mizuno K, Yakura H: Selective regulation of Lyn tyrosine kinase by CD45 in immature B cells. J Biol Chem 1995;270:27987-27990.
32. Tan X, Stover DR, Walsh KA: Demonstration of protein tyrosine phosphatase activity in the second of two homologous domains of CD45. J Biol Chem 1993;268:6835-6838.
33. Flint AJ, Gebbink MF, Franza BR Jr, Hill DE, Tonks NK: Multisite phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation. EMBO J 1993;12:1937-1946.
34. Brown-Shimer S, Johnson KA, Hill DE, Bruskin AM: Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res 1992;52:478-482.
35. Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW: Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 1993;53(10 Suppl):2272-2278.
36. Cool DE, Tonks NK, Charbonneau H, Fischer EH, Krebs EG: Expression of a human T-cell protein-tyrosine-phosphatase in baby hamster kidney cells. Proc Natl Acad Sci U S A 1990;87:280-7284.
37. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-160.
38. Nagase H, Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
39. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998;281:1312-1316.
40. Green DR: Apoptotic pathways: the roads to ruin. Cell 1998;94:695-698.
41. Cohen MC, Cohen S: Cytokine function: a study in biologic diversity. Am J Clin Pathol 1996;105:589-598.
42. Ishihara K, Hirano T: IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002;13:357-368.
43. Henderson B, Blake S: Therapeutic potential of cytokine manipulation. Trends Pharmacol Sci 1992;13:145-152.
44. Han SB, Park SH, Jeon YJ, Kim YK, Kim HM, Yang KH: Prodigiosin blocks T cell activation by inhibiting interleukin-2R expression and delays progression of autoimmune diabetes and collagen-induced arthritis. J Pharmacol Exp Ther 2001;299:415-425.
45. Zenke G, Strittmatter U, Fuchs S, Quesniaux VFJ, Brinkmann V, Schuler W, Zurini M, Enz A, Billich A, Sanglier JJ, Fehr T: Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action. J Immunol 2001;166:7165-7171.
46. Ron D, Kazanietz MG: New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 1999;13:1658-1676.